Telavancin

BreastfeedingPediatric
  • TRADE NAME: Vibativ (Astellas)
  • INDICATIONS: Complicated skin and skin structure infections (cSSSI)
  • CLASS: Antibiotic, lipoglycopeptide
  • HALF-LIFE: 7–10 hours

Contra-indicated in patients with known hypersensitivity to vancomycin.

FETAL RISK

See full prescribing information for complete boxed warning.

Our database has 41 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
LOCAL
RENAL
RESPIRATORY
OTHER


Page last updated 09/16/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top